Archives

The Impact of Specialty Pharmacy on Clinician Allocation 204 115 Shields Health Solutions

The Impact of Specialty Pharmacy on Clinician Allocation

This white paper discusses how hospitals and health systems can minimize the time spent by physicians and nursing staff to complete administrative tasks that are associated with starting patients on specialty medications, enabling clinicians to focus on delivering patient care.
Pediatric Patients Benefit from An Integrated Specialty Pharmacy Care Model 204 115 Shields Health Solutions

Pediatric Patients Benefit from An Integrated Specialty Pharmacy Care Model

This white paper describes how an integrated specialty pharmacy can help alleviate the burden on health systems and their patients.
Shields RA Outcomes 216 115 Shields Health Solutions

Shields RA Outcomes

RA is an autoimmune and inflammatory disease where the immune system attacks healthy cells, causing inflammation and painful swelling in the affected parts of the body.

Shields MS Outcomes 216 115 Shields Health Solutions

Shields MS Outcomes

MS is a chronic, autoimmune disease of the central nervous system, affecting the communication between the brain and other parts of the body

Shields Hep-C Outcomes 216 115 Shields Health Solutions

Shields Hep-C Outcomes

Hepatitis C is a liver infection caused by the hepatitis C virus (HCV) and is spread through contact with the blood of an infected person.

The Challenge of Financial Toxicity in Cancer Care: a Focus on Oral Oncology 204 115 Shields Health Solutions

The Challenge of Financial Toxicity in Cancer Care: a Focus on Oral Oncology

This white paper describes how an integrated specialty pharmacy can help alleviate the burden on health systems and their patients.
Shields Health Solutions Consistently Demonstrates Superior Clinical Outcomes 204 115 Shields Health Solutions

Shields Health Solutions Consistently Demonstrates Superior Clinical Outcomes

STOUGHTON, Mass.–(BUSINESS WIRE)–Shields Health Solutions (Shields), the premier specialty pharmacy accelerator in the country, recently published its latest patient outcomes in key disease states such as hepatitis C, HIV, rheumatoid arthritis (RA),…

Shields Health Solutions and Erlanger Partner to Introduce Specialty Pharmacy Services 204 115 Shields Health Solutions

Shields Health Solutions and Erlanger Partner to Introduce Specialty Pharmacy Services

STOUGHTON, Mass. & CHATTANOOGA, Tenn.–(BUSINESS WIRE)–Shields Health Solutions (Shields), the premier specialty pharmacy accelerator in the country, announced today that it has partnered with Tennessee-based Erlanger to establish a new specialty pharmacy…

PAH Care Model Provides a Road Map for Rare Disease Treatment 204 115 Shields Health Solutions

PAH Care Model Provides a Road Map for Rare Disease Treatment

The Shields Health Solutions care model for helping pharmacies and providers treat patients with pulmonary arterial hypertension (PAH) integrates a patient’s entire care team, and can be adopted to successfully…